IKS applies laboratory expertise to motorcycling

Sets up racing team and uses XiltriX to monitor racing performance of rider Mervyn Verploegen

IKS International, a Netherlands-based laboratory monitoring specialist and autoclave supplier, has stepped outside its science comfort zone to set up a motorcycle racing team. Rising young Dutch star, Mervyn Verploegen, will be the team’s rider in the Dutch National Talent Cup.

According to IKS md Stephen Tierney, this is not just the usual sponsorship arrangement: IKS will be applying the expertise accumulated in more than 20 years of laboratory monitoring to improve racing performance.

‘We’re delighted to be able to help this young talent advance his sporting career and to support his family, who are very much involved,’ he said. ‘Unusually in such situations, though, we can also contribute technically by applying the technology employed in our XiltriX laboratory monitoring systems to measuring parameters such as tyre temperature and pressure that have a significant impact on racing performance.’

He added: ‘Motor racing is pure adrenaline, but control is vital: our traditional markets are rather more conservative and sometimes slow moving, but control is every bit as important. We like to think that being involved in two such different environments will help develop the progressive and innovative philosophy that will drive our company forward.’

IKS International, based in Rosmalen, near 's-Hertogenbosch, supplies advanced products and services to clinical, biotechnology, pharmaceutical and microbiology laboratories worldwide.

You may also like

Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing

Piramal Pharma Solutions announces partnership with Botanix to support drug substance development

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing

ProtaGene and Merck partner to deliver end-to-end biologics testing

The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle
Subscribe now